- Home
- SMTC vs ACLX Comparison
SMTC vs ACLX Comparison
Compare SMTC & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMTC
- ACLX
- Stock Information
- Founded
- SMTC 1960
- ACLX 2015
- Country
- SMTC United States
- ACLX United States
- Employees
- SMTC N/A
- ACLX N/A
- Industry
- SMTC Semiconductors
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- SMTC Technology
- ACLX Health Care
- Exchange
- SMTC Nasdaq
- ACLX Nasdaq
- Market Cap
- SMTC 4.3B
- ACLX 4.1B
- IPO Year
- SMTC N/A
- ACLX 2022
- Fundamental
- Price
- SMTC $62.22
- ACLX $76.42
- Analyst Decision
- SMTC Strong Buy
- ACLX Strong Buy
- Analyst Count
- SMTC 13
- ACLX 13
- Target Price
- SMTC $60.54
- ACLX $114.75
- AVG Volume (30 Days)
- SMTC 2.0M
- ACLX 507.4K
- Earning Date
- SMTC 08-25-2025
- ACLX 11-06-2025
- Dividend Yield
- SMTC N/A
- ACLX N/A
- EPS Growth
- SMTC N/A
- ACLX N/A
- EPS
- SMTC 0.29
- ACLX N/A
- Revenue
- SMTC $996,476,000.00
- ACLX $56,979,000.00
- Revenue This Year
- SMTC $15.91
- ACLX N/A
- Revenue Next Year
- SMTC $9.30
- ACLX $174.18
- P/E Ratio
- SMTC $217.16
- ACLX N/A
- Revenue Growth
- SMTC 22.22
- ACLX N/A
- 52 Week Low
- SMTC $24.05
- ACLX $47.86
- 52 Week High
- SMTC $79.52
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- SMTC 66.56
- ACLX 61.10
- Support Level
- SMTC $59.71
- ACLX $73.16
- Resistance Level
- SMTC $63.25
- ACLX $78.61
- Average True Range (ATR)
- SMTC 2.20
- ACLX 2.84
- MACD
- SMTC 0.12
- ACLX 0.55
- Stochastic Oscillator
- SMTC 85.64
- ACLX 75.42
About SMTC Semtech Corporation
Semtech Corp is engaged in designing, developing, manufacturing and marketing analog and mixed-signal semiconductors, algorithms and wireless semiconductors, connectivity modules, gateways, routers and connected services for IoT. The company operates in four reportable segments: Signal Integrity, Analog Mixed Signal and Wireless, IoT Systems and IoT Connected Services. The majority of the company's revenue is earned through Analog Mixed Signal and Wireless segment. Geographically majority of the company's revenue is earned from Asia Pacific region, company also operates in North America and Europe.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.